Owned and Operated by Full-Time Physician Investigators
Understanding of Clinical Research
Anyone in the industry knows that expertise as a physician does not necessarily translate to expertise as a principal investigator. Our principal investigators have a combined 47 years of experience in clinical research, clinical pharmacology and translational research that enables them to understand the particular demands and needs of your clinical trial and your team. We will feather into your team and will immediately add value without having to be managed. Our investigators are exceptionally involved and responsive to the needs of our sponsors and our participants.
Level of Involvement
The quality of research is most closely and directly related to degree of physician investigator involvement. In addition, close medical oversight is acutely important in early drug development. Providence Clinical Research can offer exceptional medical oversight of your clinical trial with two full-time, on-site certified physician investigators.
Breadth and Depth of Clinical Research Experience
Our investigators' experience spans the industry from medicinal biochemistry and preclinical bench development to manufacturing, quality control, quality assurance and regulatory affairs. In the clinical development arena they have gained experience as IRB members, coordinators, monitors, auditors and then principal investigators. They have been involved in all types of clinical development, including biologics, vaccines, therapeutics, devices, diagnostics, implantables, injectables, consumer products, dietary supplements, serologicals and genomics/proteomics. Phases of development within drugs and biologics have included all types of Phase I, Phase II-IV, postmarketing, Rx to OTC, and pharmacoeconomic.
PCR's Expertise and Focus
Providence Clinical Research brings all of this experience to focus on the nexus of translational research: guiding new therapeutics from preclinical into clinicals and through the early clinical development phases. We focus on efforts that streamline the drug development process: early drug development trials such as first in man, SAD, MAD, pharmacokinetic, pharmacodynamic. We have experience and excellent access to most indications and special populations for these early phase studies. We do proof of concept, Phase I/II, pharmacogenomic, pharmacoproteomic, and on into streamlined Phase II and III studies.
Our Principal Investigators
Teresa Sheahan Sligh, MD, CPI
has been involved in biomedical and clinical research since 1982. She has been certified as a physician investigator by the APPI since 2004. Starting as a medicinal biochemist, she gained experience with preclinical development, development of manufacturing and QC methods and then clinical development project management. After training in Internal Medicine she started and operated several high-performing investigative sites as the full-time PI on more than 80 clinical trials with an exceptional track record of quality and meeting enrollment goals.
Scott Preston Sligh, MD, RPh
has been involved in clinical pharmacology since 1987. He utilized his pharmacy degree in hospital, retail and home-IV settings before going on to obtain a medical degree with honors and then completing residency in General Surgery and two fellowships in Colorectal Surgery and Anorectal Physiology. Since 2000, he has been investigator on 75 trials. In 2007 he made the transition to full-time investigator.
Physician Network: PCR Investigators
PCR has a network of board certified physician investigators in the following therapeutic areas:
|
|
|
PCR recognizes the tremendous national shortage of competent clinical investigators. We also understand the demands on investigators in an already challenging medical environment. We understand how to provide optimal support to investigators so that clinical research becomes an enjoyable, rewarding and productive addition to their practice. We provide the resources and flexibility for physicians to engage in pharmaceutical, device and biotech clinical research trials to the degree that they choose. These resources allow our investigators to achieve additional revenue, provide patients with cutting-edge therapies, participate in medical advancements in their specialty, and build reputations as key opinion leaders within the medical and biopharmaceutical communities. We strive to enhance existing physician-patient relationships.
PCR provides support to new investigators, access to additional trials in order to expand their current trial operations and/or a more cost-effective way to augment their clinical research staff during the normal fluctuations in study volume.
Our professional, multi-lingual staff provides the following services:
Protocol Procurement & Review
Resource Planning and Staffing
Budget & Contracts Negotiation
Local and Central IRB Approval Processes
Document Management
Study Initiation
Screening/Enrollment Procedures
Case Report Form Completion, Correction and Archival
Data/QA Management
Study Communications
Site Close-Out
Coordination of FDA/Sponsor Audits
PCR also provides highly skilled Clinical Research Professionals to manage each study patient in the investigators office(s) on a prn basis, giving them a cost-effective alternative to maintaining a fully staffed research office in an environment of fluctuating billable work.
PCR works with each investigator to tailor support services to meet their specific needs.
